Activation of Notch1 signalling promotes multi-lineage differentiation of c-KitPOS/NKX2.5POS bone marrow stem cells: Implication in stem cell translational medicine

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Ding, Ranran ^a   Jiang, Xiaofan ^a   Ha, Yanping ^a   Wang, Zhenliang ^a   Guo, Junli ^b   Jiang, Hanguo ^a   Zheng, Shaojiang ^b   Shen, Zhihua ^a   Jie, Wei ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NKX2.5; ACTIN BINDING PROTEIN; CALCIUM BINDING PROTEIN; HOMEOBOX PROTEIN NKX-2.5; HOMEODOMAIN PROTEIN; JAG1 PROTEIN, RAT; MEMBRANE PROTEIN; MUSCLE PROTEIN; NKX2.5 PROTEIN, RAT; NOTCH1 PROTEIN, RAT; PROTEIN JAGGED 1; SERRATE JAGGED PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TRANSGELIN; TROPONIN T; VON WILLEBRAND ANTIGEN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; ANIMAL; BONE MARROW CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ENDOTHELIAL CELLS; HOMEOBOX PROTEIN NKX-2.5; HOMEODOMAIN PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAGGED-1 PROTEIN; MEMBRANE PROTEINS; MESENCHYMAL STROMAL CELLS; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; MUSCLE PROTEINS; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH1; SERRATE-JAGGED PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TROPONIN T; VON WILLEBRAND FACTOR;

EID: 84929791885     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0085-2     Document Type: Article

References (45)

1. Malliaras K, Marban E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull. 2011;98:161-85.
2. Leri A, Kajstura J, Anversa P, Frishman WH. Myocardial regeneration and stem cell repair. Curr Probl Cardiol. 2008;33:91-153.
3. Jakob P, Landmesser U. Current status of cell-based therapy for heart failure. Curr Heart Fail Rep. 2013;10:165-76.
4. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-Term improvement in cardiac parameters: A systematic review and meta-Analysis. Circulation. 2012;126:551-68.
5. Surder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S, et al. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation. 2013;127:1968-79.
6. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al. Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61:2329-38.
7. Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I, et al. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: The CELLWAVE randomized clinical trial. JAMA. 2013;309:1622-31.
8. Leri A, Anversa P. Stem cells: bone-marrow-derived cells and heart failure-The debate goes on. Nat Rev Cardiol. 2013;10:372-3.
9. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-76.
10. Ellison GM, Vicinanza C, Smith AJ, Aquila I, Leone A, Waring CD, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013;154:827-42.
11. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-57.
12. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet. 2012;379:895-904.
13. Kan I, Melamed E, Offen D. Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets. 2005;6:31-41.
14. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923-40.
15. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216-33.
16. Koch U, Lehal R, Radtke F. Stem cells living with a Notch. Development. 2013;140:689-704.
17. Boni A, Urbanek K, Nascimbene A, Hosoda T, Zheng H, Delucchi F, et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A. 2008;105:15529-34.
18. Schwanbeck R, Martini S, Bernoth K, Just U. The Notch signaling pathway: molecular basis of cell context dependency. Eur J Cell Biol. 2011;90:572-81.
19. Yu J, Li M, Qu Z, Yan D, Li D, Ruan Q. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. J Cardiovasc Pharmacol. 2010;55:496-505.
20. Grassel S, Stockl S, Jenei-Lanzl Z. Isolation, culture, and osteogenic/chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Methods Mol Biol. 2012;879:203-67.
21. Zheng YH, Xiong W, Su K, Kuang SJ, Zhang ZG. Multilineage differentiation of human bone marrow mesenchymal stem cells and. Exp Ther Med. 2013;5:1576-80.
22. Guo J, Jie W, Kuang D, Ni J, Chen D, Ao Q, et al. Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway. Int J Exp Pathol. 2009;90:355-64.
23. Guo J, Jie W, Shen Z, Li M, Lan Y, Kong Y, et al. SCF increases cardiac stem cell migration through PI3K/AKT and MMP2/9 signaling. Int J Mol Med. 2014;34:112-8.
24. Prins HJ, Braat AK, Gawlitta D, Dhert WJ, Egan DA, Tijssen-Slump E, et al. In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells. Stem Cell Res. 2014;12:428-40.
25. Kuang D, Zhao X, Xiao G, Ni J, Feng Y, Wu R, et al. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol. 2008;103:265-73.
26. He JQ, Vu DM, Hunt G, Chugh A, Bhatnagar A, Bolli R. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One. 2011;6, e27719.
27. Miyamoto S, Kawaguchi N, Ellison GM, Matsuoka R, Shin'oka T, Kurosawa H. Characterization of long-Term cultured c-kit + cardiac stem cells derived from adult rat hearts. Stem Cells Dev. 2010;19:105-16.
28. Doppler SA, Deutsch MA, Lange R, Krane M. Cardiac regeneration: current therapies-future concepts. J Thorac Dis. 2013;5:683-97.
29. Quijada P, Sussman MA. Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther. 2014;12:1275-88.
30. Haack-Sorensen M, Hansen SK, Hansen L, Gaster M, Hyttel P, Ekblond A, et al. Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion. Stem Cell Rev. 2013;9:44-58.
31. Martin-Rendon E, Brunskill S, Doree C, Hyde C, Watt S, Mathur A, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2008;4, CD006536.
32. Figeac F, Lesault PF, Le Coz O, Damy T, Souktani R, Trebeau C, et al. Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells. Stem Cells. 2014;32:216-30.
33. Siegel G, Krause P, Wohrle S, Nowak P, Ayturan M, Kluba T, et al. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev. 2012;21:2457-70.
34. Urbanek K, Cabral-da-Silva MC, Ide-Iwata N, Maestroni S, Delucchi F, Zheng H, et al. Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. Circ Res. 2010;107:429-41.
35. Li H, Yu B, Zhang Y, Pan Z, Xu W. Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun. 2006;341:320-5.
36. Kubo H, Berretta RM, Jaleel N, Angert D, Houser SR. c-Kit + bone marrow stem cells differentiate into functional cardiac myocytes. Clin Transl Sci. 2009;2:26-32.
37. Khan M, Mohsin S, Khan S, Riazuddin S. Lin-c-kit(+) BM-derived stem cells repair Infarcted Heart. J Stem Cells Regen Med. 2010;6:15-25.
38. Gude N, Sussman M. Notch signaling and cardiac repair. J Mol Cell Cardiol. 2012;52:1226-32.
39. Chen L, Ashraf M, Wang Y, Zhou M, Zhang J, Qin G, et al. The role of notch 1 activation in cardiosphere derived cell differentiation. Stem Cells Dev. 2012;21:2122-9.
40. Schroeder T, Meier-Stiegen F, Schwanbeck R, Eilken H, Nishikawa S, Hasler R, et al. Activated Notch1 alters differentiation of embryonic stem cells into mesodermal cell lineages at multiple stages of development. Mech Dev. 2006;123:570-9.
41. Matsuda T, Miyagawa S, Fukushima S, Kitagawa-Sakakida S, Akimaru H, Horii-Komatsu M, et al. Human cardiac stem cells with reduced notch signaling show enhanced therapeutic potential in a rat acute infarction model. Circ J. 2013;78:222-31.
42. Li Y, Hiroi Y, Ngoy S, Okamoto R, Noma K, Wang CY, et al. Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation. 2011;123:866-76.
43. Smits AM, van Vliet P, Hassink RJ, Goumans MJ, Doevendans PA. The role of stem cells in cardiac regeneration. J Cell Mol Med. 2005;9:25-36.
44. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346:5-15.
45. Guo HD, Wang HJ, Tan YZ, Wu JH. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A. 2011;17:45-58.